Related Experiment Videos
Cholinergic dysfunction in cognitive impairments after aneurysmal subarachnoid hemorrhage
Takao Nozaki1, Naoto Sakai, Haruyuki Oishi
1Department of Neurosurgery, Shimizu Kosei Hospital, Japan.
Neurosurgery
|September 18, 2002
Summary
Cognitive impairments after subarachnoid hemorrhage (SAH) may stem from cholinergic dysfunction. A tropicamide drop test revealed significantly greater pupil dilation in patients with cognitive deficits, suggesting a potential therapeutic target.
Area of Science:
- Neuroscience
- Neurology
- Ophthalmology
Background:
- Cognitive impairments are common sequelae of subarachnoid hemorrhage (SAH).
- The neurobiological underpinnings of post-SAH cognitive deficits remain largely unexplored.
- Cholinergic system dysfunction is implicated in cognitive decline.
Purpose of the Study:
- To investigate cholinergic function in patients following aneurysmal SAH.
- To assess the utility of the tropicamide drop test, a measure of cholinergic function, in post-SAH patients.
- To correlate pupillary response to tropicamide with cognitive status.
Main Methods:
- Seventeen surgically treated aneurysmal SAH patients were categorized into two groups based on Mini-Mental State Examination (MMSE) scores.
- The tropicamide drop test was administered, measuring pupil diameter before and after instillation of tropicamide or saline.
- Pupil dilation ratios were calculated to assess cholinergic response.
Main Results:
- Patients with lower MMSE scores (Group B) exhibited a trend towards higher mean pupil dilation ratios compared to those with higher scores (Group A), though not statistically significant (P=0.18).
- The relative dilation ratio (comparing tropicamide-affected eye to saline-affected eye) was significantly higher in Group B (1.41 ± 0.36) than in Group A (1.06 ± 0.20) (P < 0.05).
Conclusions:
- The study identified cholinergic dysfunction in patients experiencing cognitive impairment after SAH.
- Pupillary response to tropicamide serves as a biomarker for cognitive deficits post-SAH.
- These findings offer insights into the pathophysiology of cognitive impairment following SAH and may inform future therapeutic strategies.